New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export ISRG’s income statement to Excel — free account
Intuitive Surgical, Inc.
ISRGHealthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024.
- Revenue
- +21.7%
- EPS
- −23.6%
- Free cash flow
- +51.0%
Quarter to September 2026, against a year earlier
399.33
7.91
−1.94%
After hours trading: 400.00, up 0.17%, last trade 4:23pm Eastern.
Follow ISRG
Alert me
Revenue to profit Q3 FY2026, quarter to Sep 30, 2026
Of every $100 of revenue, $17.20 was left as profit. Gross margin has risen two quarters running, from 66.1% to 68.4%. What is an income statement?
| Revenue | 3.0 | 100.0% |
|---|---|---|
| Cost of revenue | −1.0 | −31.6% |
| Gross profit | 2.1 | 68.4% |
| Research & development | −0.4 | −13.4% |
| Selling, general & admin | −0.6 | −20.8% |
| Other operating costs | −0.5 | −14.8% |
| Operating income | 0.6 | 19.4% |
| Other income, net | +0.1 | 2.5% |
| Income tax | −0.1 | −4.7% |
| Net income | 0.5 | 17.2% |
Net margin (right axis)
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Revenue | $2.9B | $2.8B | $2.9B | $3.0B |
| Operating income | $864M | $855M | $972M | $593M |
| Net income | $800M | $826M | $823M | $524M |
| Net margin (right axis) | 27.9% | 29.8% | 28.5% | 17.2% |
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Revenue |
3,048.70 | 2,892.30 | 2,770.80 | 2,866.20 |
+8 more quarters Free account |
Revenue Growth |
21.70% | 18.54% | 22.96% | 18.76% | |
Cost of Revenue |
964.40 | 931.90 | 940.30 | 961.90 | |
Gross Profit |
2,084.30 | 1,960.40 | 1,830.50 | 1,904.30 | |
R&D Expenses |
408.30 | 370.60 | 361.90 | 352.90 | |
SG&A Expenses |
633.40 | 617.90 | 613.30 | 687.10 | |
Operating Income |
592.60 | 971.90 | 855.30 | 864.30 | |
Non-operating Income/Expense |
75.80 | 82.70 | 85.10 | 91.30 | |
| 668.40 | 1,054.60 | 940.40 | 955.60 | ||
Income Tax Provision |
144.00 | 231.40 | 114.40 | 156.10 | |
Income after Tax |
524.40 | 823.20 | 826.00 | 799.50 | |
Dividends (Preferred) |
0.00 | 0.00 | — | — | |
Non-Controlling Interest |
1.60 | 5.10 | 4.50 | 4.70 | |
Net Income Common |
522.80 | 818.10 | 821.50 | 794.80 | |
EPS (Basic) |
1.50 | 2.31 | 2.31 | 2.24 | |
EPS (Diluted) |
1.49 | 2.29 | 2.28 | 2.21 | |
Shares (Basic, Weighted) |
349.00 | 354.10 | 354.90 | 356.90 | |
Shares (Diluted, Weighted) |
351.60 | 357.30 | 359.80 | 362.70 | |
Gross Margin |
68.37% | 67.78% | 66.06% | 66.44% | |
EBIT Margin |
19.44% | 33.60% | 30.87% | 30.15% | |
EBT margin |
21.92% | 36.46% | 33.94% | 33.34% | |
Net Profit Margin |
17.15% | 28.29% | 29.65% | 27.73% | |
EBITDA |
796.40 | 1,194.20 | 1,045.10 | 1,100.10 | |
EBIT |
592.60 | 971.90 | 855.30 | 864.30 | |
Income from Continuous Operations |
524.40 | 823.20 | 826.00 | 799.50 | |
Consolidated Net Income/Loss |
524.40 | 823.20 | 826.00 | 799.50 | |
EPS (Basic, from Continuous Ops) |
1.50 | 2.32 | 2.33 | 2.25 | |
EPS (Diluted, from Cont. Ops) |
1.49 | 2.30 | 2.30 | 2.22 | |
EPS (Basic, Consolidated) |
1.50 | 2.32 | 2.33 | 2.25 | |
EPS (Diluted, Consolidated) |
1.49 | 2.30 | 2.30 | 2.22 | |
Shares (Diluted, Average) |
351.60 | 357.30 | 359.80 | 360.40 | |
EBITDA Margin |
26.12% | 41.29% | 37.72% | 38.38% | |
Operating Cash Flow Margin |
40.15% | 36.68% | 32.91% | 31.14% |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 2, 2026